2004 American College of Cardiology/American Heart Association guidelines for the management of patients with ST-elevation myocardial infarction: Implications for emergency department practice

Annals of Emergency Medicine

Volumn 45, Issue 4, 2005, Pages 363-376

  Pollack Jr , Charles V ^a   Diercks, Deborah B ^b   Roe, Matthew T ^c   Peterson, Eric D ^c  

^a PENNSYLVANIA HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANISTREPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; MORPHINE SULFATE; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TIROFIBAN; UROKINASE; VERAPAMIL;

ANGINA PECTORIS; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; DIABETES MELLITUS; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG FATALITY; ELECTROCARDIOGRAM; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE TACHYCARDIA; HUMAN; MEDICAL SOCIETY; META ANALYSIS; PATIENT TRANSPORT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION; SYSTEMATIC REVIEW; THORAX PAIN; THROMBOCYTOPENIA; TORSADE DES POINTES; ARTICLE; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; PATHOPHYSIOLOGY; STANDARD;

ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION;

EID: 17844386574     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2004.11.003     Document Type: Article

References (97)

1. R.M. Gunnar, E.R. Passamani, and P.D. Bourdillon Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol 16 1990 249 292
2. T.J. Ryan, J.L. Anderson, and E.M. Antman ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 28 1996 1328 1428
3. T.J. Ryan, E.M. Antman, and N.H. Brooks 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 34 1999 890 911
4. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) J Am Coll Cardiol 36 2000 970 1062
5. C.V. Pollack, and W.B. Gibler 2000 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a practical summary for emergency physicians Ann Emerg Med 38 2001 229 240
6. C.V. Pollack, and W.B. Gibler Advances create opportunities: implementing the major tenets of the new unstable angina guidelines in the emergency department Ann Emerg Med 38 2001 241 248
7. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Available at: http://www.acc.org/clinical/ guidelines/unstable/unstable.pdf. Accessed September 1, 2004.
8. C.V. Pollack, M.T. Roe, and E.D. Peterson 2002 Update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice Ann Emerg Med 41 2003 355 369
9. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Available at: http://www.acc.org/ clinical/guidelines/stemi/index.pdf. Accessed August 27, 2004.
10. W.S. Leslie, A. Urie, and J. Hooper Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care Heart 84 2000 137 141
11. A.B. Simon, M. Feinleib, and H.K. Thompson Components of delay in the pre-hospital phase of acute myocardial infarction Am J Cardiol 30 1972 476 482
12. J.G. Canto, R.J. Zalenski, J.P. Ornato for the National Registry of Myocardial Infarction 2 Investigators Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2 Circulation 106 2002 3018 3023
13. R.O. Cummins From concept to standard-of-care? Review of the clinical experience with automated external defibrillators Ann Emerg Med 18 1989 1269 1275
14. R.O. Cummins, J.A. Schubach, and P.E. Litwin Training lay persons to use automatic external defibrillators: success of initial training and one-year retention of skills Am J Emerg Med 7 1989 143 149
15. V.N. Mosesso, E.A. Davis, and T.E. Auble Use of automated external defibrillators by police officers for treatment of out-of-hospital cardiac arrest Ann Emerg Med 32 1998 200 207
16. T.D. Valenzuela, D.J. Roe, and G. Nichol Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos N Engl J Med 343 2000 1206 1209
17. R.L. Page, J.A. Joglar, and R.C. Kowal Use of automated external defibrillators by a US airline N Engl J Med 343 2000 1210 1216
18. J.P. Ornato, E.M. Racht, and J.J. Fitch The need for ALS in urban and suburban EMS systems Ann Emerg Med 19 1990 1469 1470
19. M.J. Eisenberg, and E.J. Topol Prehospital administration of aspirin in patients with unstable angina and acute myocardial infarction Arch Intern Med 156 1996 1506 1510
20. P.W. Armstrong, D. Collen, and E. Antman Fibrinolysis for acute myocardial infarction: the future is here and now Circulation 107 2003 2533 2537
21. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients Lancet 343 1994 311 322
22. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 402
23. W.D. Weaver, M. Cerqueira, and A.P. Hallstrom Prehospital-initiated vs hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention trial JAMA 270 1993 1211 1216
24. W.T. Hermens, G.M. Willems, and K.M. Nijssen Effect of thrombolytic treatment delay on myocardial infarct size [letter] Lancet 340 1992 1297
25. B.J. Gersh, and J.L. Anderson Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm: paradoxic or predictable? Circulation 88 1993 296 306
26. L.K. Newby, W.R. Rutsch, R.M. Califf for the GUSTO-1 Investigators Time from symptom onset to treatment and outcomes after thrombolytic therapy J Am Coll Cardiol 27 1996 1646 1655
27. J.J. Milavetz, D.W. Giebel, and T.F. Christian Time to therapy and salvage in myocardial infarction J Am Coll Cardiol 31 1998 1246 1251
28. P. Chareonthaitawee, R.J. Gibbons, R.S. Roberts for the CORE investigators (Collaborative Organisation for RheothRx Evaluation) The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction Heart 84 2000 142 148
29. The European Myocardial Infarction Project Group Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction N Engl J Med 329 1993 383 389
30. P.G. Steg, E. Bonnefoy, and S. Chabaud Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial Circulation 108 2003 2851 2856
31. P. Widimsky, T. Budesinsky, and D. Vorac Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial - PRAGUE-2 Eur Heart J 24 2003 94 104
32. D.K. Pedley, K. Bissett, and E.M. Connolly Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics BMJ 327 2003 22 26
33. J.S. Hochman, L.A. Sleeper, H.D. White for the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Investigators One-year survival following early revascularization for cardiogenic shock JAMA 285 2001 190 192
34. E.J. Topol, and D.J. Kereiakes Regionalization of care for acute ischemic heart disease: a call for specialized centers Circulation 107 2003 1463 1466
35. R.M. Califf, and D.P. Faxon Need for centers to care for patients with acute coronary syndromes Circulation 107 2003 1467 1470
36. J.T. Willerson Editor's commentary: centers of excellence Circulation 107 2003 1471 1472
37. M.E. Farkouh, P.A. Smars, G.S. Reeder for the Chest Pain Evaluation in the Emergency Room (CHEER) Investigators A clinical trial of a chest-pain observation unit for patients with unstable angina N Engl J Med 339 1998 1882 1888
38. C.P. Cannon, E.M. Antman, and R. Walls Time as an adjunctive agent to thrombolytic therapy J Thromb Thrombolysis 1 1994 27 34
39. I.B. Menown, G. Mackenzie, and A.A. Adgey Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction Eur Heart J 21 2000 275 283
40. R.V. Luepker, F.S. Apple, and R.H. Christenson Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation 108 2003 2543 2549
41. J.E. Adams, D.R. Abendschein, and A.S. Jaffe Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation 88 1993 750 763
42. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) [American College of Cardiology Web site]. Available at: http://www.acc.org/clinical/guidelines/echo/index.pdf. Accessed August 28, 2004.
43. R.E. Waters, K.P. Singh, and M.T. Roe Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction J Am Coll Cardiol 43 2004 2153 2159
44. M. Aubier, T. Trippenbach, and C. Roussos Respiratory muscle fatigue during cardiogenic shock J Appl Physiol 51 1981 499 508
45. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
46. M.D. Cheitlin, A.M. Hutter, and R.G. Brindis ACC/AHA expert consensus document on the use of sildenafil (Viagra) in patients with cardiovascular disease: American College of Cardiology/American Heart Association J Am Coll Cardiol 33 1999 273 282
47. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
48. The MIAMI Trial Research Group Metoprolol in acute myocardial infarction: patient population Am J Cardiol 56 1985 10G 14G
49. N. Freemantle, J. Cleland, and P. Young Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
50. R. Roberts, W.J. Rogers, and H.S. Mueller Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study Circulation 83 1991 422 437
51. F. Van de Werf, L. Janssens, and T. Brzostek Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardic agent in patients with acute myocardial infarction receiving thrombolytic therapy J Am Coll Cardiol 22 1993 407 416
52. M. Pfisterer, J.L. Cox, and C.B. Granger Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience: Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries J Am Coll Cardiol 32 1998 634 640
53. R. Collins, R. Peto, and C. Baigent Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction N Engl J Med 336 1997 847 860
54. P.R. Eisenberg Role of heparin in coronary thrombolysis Chest 101 1992 131S 139S
55. A.K. Rao, C. Pratt, and A. Berke Thrombolysis in Myocardial Infarction (TIMI) Trial: phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
56. J.J. Popma, R.M. Califf, and S.G. Ellis Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic study J Am Coll Cardiol 20 1992 1305 1312
57. T.E. Warkentin, M.N. Levine, and J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
58. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 2001 605 613
59. G. Montalescot, P. Barragan, O. Wittenberg for the Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up (ADMIRAL) Investigators Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903
60. G.W. Stone, C.L. Grines, D.A. Cox for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
61. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: part 6: advanced cardiovascular life support: section 5: pharmacology I: agents for arrhythmias: the American Heart Association in collaboration with the International Liaison Committee on Resuscitation Circulation 102 2000 I112 I128
62. The Danish Study Group on Verapamil in Myocardial Infarction Verapamil in acute myocardial infarction Eur Heart J 5 1984 516 528
63. The Multicenter Diltiazem Postinfarction Trial Research Group The effect of diltiazem on mortality and reinfarction after myocardial infarction N Engl J Med 319 1988 385 392
64. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
65. D.J. Magid, B.N. Calonge, J.S. Rumsfeld for the National Registry of Myocardial Infarction 2 and 3 Investigators Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy JAMA 284 2000 3131 3138
66. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
67. R.G. Wilcox, G. von der Lippe, and C.G. Olsson Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET) Lancet 2 1988 525 530
68. AIMS Trial Study Group Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study Lancet 335 1990 427 431
69. F. Van de Werf Thrombolysis for acute myocardial infarction: why is there no extra benefit after hospital discharge? Circulation 91 1995 2862 2864
70. H.D. White Thrombolytic therapy in the elderly Lancet 356 2000 2028 2030
71. L.M. Brass, J.H. Lichtman, and Y. Wang Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project Stroke 31 2000 1802 1811
72. J.H. Gurwitz, J.M. Gore, R.J. Goldberg for the Participants in the National Registry of Myocardial Infarction 2 Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction Ann Intern Med 129 1998 597 604
73. M.L. Simoons, A.P. Maggioni, and G. Knatterud Individual risk assessment for intracranial haemorrhage during thrombolytic therapy Lancet 342 1993 1523 1528
74. M.A. Sloan, R.P. Guigliano, and S.L. Thompson Prediction of intracranial hemorrhage in the InTIME-II trial J Am Coll Cardiol 37 2001 372A
75. R.M. Walls, C.V. Pollack, and NEAR Investigators Successful cricothyrotomy after thrombolytic therapy for acute myocardial infarction: a report of two cases Ann Emerg Med 35 2000 188 191
76. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial: Assessment of the Safety and Efficacy of a New Thrombolytic Investigators Lancet 354 1999 716 722
77. J.M. Gore, C.B. Granger, and M.L. Simoons Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial: Global Use of Strategies to Open Occluded Coronary Arteries Circulation 92 1995 2811 2818
78. M.A. Sloan, C.A. Sila, and K.W. Mahaffey Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage Circulation 98 1998 1376 1382
79. E.M. Holper, R.P. Giugliano, and E.M. Antman Glycoprotein IIb/IIIa inhibitors in acute ST-segment myocardial infarction Coronary Artery Dis 10 1999 567 573
80. E.M. Antman, R.P. Giugliano, C.M. Gibson for the TIMI-14 Investigators Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial Circulation 99 1999 2720 2732
81. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group Trial of abciximab with and without low-dose reteplase for acute myocardial infarction Circulation 101 2000 2788 2794
82. S.J. Brener, U. Zeymer, and A.A. Adgey Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the Integrilin and Low-Dose Thrombolysis in Acute Myocardial Infarction (INTRO AMI) trial J Am Coll Cardiol 39 2002 377 386
83. E.J. Topol for the GUSTO V Investigators Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial Lancet 357 2001 1905 1914
84. W.D. Weaver, R.J. Simes, and A. Betriu Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review JAMA 278 1997 2093 2098
85. C. Grines, A. Patel, and J. Zijlstra Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials Am Heart J 145 2003 47 57
86. M. Grzybowski, E.A. Clements, and L. Parsons Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis JAMA 290 2003 1891 1898
87. P.B. Berger, S.G. Ellis, and D.R. Holmes Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial Circulation 100 1999 14 20
88. C.P. Cannon, C.M. Gibson, and C.T. Lambrew Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
89. B.K. Nallamothu, and E.R. Bates Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 92 2003 824 826
90. J.M. Juliard, L.J. Feldman, and J.L. Golmard Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time Am J Cardiol 91 2003 1401 1405
91. E. Bonnefoy, F. Lapostolle, A. Leizorovicz for the Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction Study Group Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study Lancet 360 2002 825 829
92. F. Zijlstra, A.W. van't Hof, and A.L. Liem Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high-risk patients with acute myocardial infarction Heart 78 1997 333 336
93. R. Zahn, R. Schiele, and K. Seidl Primary angioplasty in acute myocardial infarction: differences between referred patients and those treated in hospitals with on-site facilities? J Invasive Cardiol 11 1999 213 219
94. E. Straumann, S. Yoon, and B. Naegeli Hospital transfer for primary coronary angioplasty in high-risk patients with acute myocardial infarction Heart 82 1999 415 419
95. A.M. Ross, K.S. Coyne, and J.S. Reiner for the Plasminogen-activator Angioplasty Compatibility Trial (PACT) investigators. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial J Am Coll Cardiol 34 1999 1954 1962
96. F. Fernandez-Aviles, J.J. Alonso, and A. Castro-Beiras Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach to acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomized controlled trial Lancet 364 2004 1045 1053
97. A. Kastrati, J. Mehilli, K. Schlotterbeck for the Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial JAMA 291 2004 947 954